Targeting CXCR4 and FAK reverses doxorubicin resistance and suppresses invasion in non-small cell lung carcinoma
Crossref DOI link: https://doi.org/10.1007/s13402-016-0304-6
Published Online: 2016-11-07
Published Print: 2017-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Dragoj, Miodrag
Milosevic, Zorica
Bankovic, Jasna
Tanic, Nikola
Pesic, Milica
Stankovic, Tijana
Funding for this research was provided by:
Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja (RS) (III41031)
License valid from 2016-11-07